On July 29, 2024, Resolian filed a notice of data breach with the Attorney General of Massachusetts after discovering that…
Read More →
On June 25, 2024, Health Canada published a notice of intent and Building resilience: Health Canada’s plan to address health…
Read More →
The Busywork of Preparing for College – Whether it’s your first, middle, or last child, sending a child off to…
Read More →
RegFi co-hosts Jerry Buckley and Sherry Safchuk welcome Orrick partner Aravind Swaminathan for a conversation exploring the critical and evolving…
Read More →
Case Name: Janssen Pharms., Inc. v. Teva Pharms. USA, Inc., No. 2022-1258, 2022-1307, 2024 WL 1355733 (Fed. Cir. Apr. 1, 2024)…
Read More →
Director Review at the Patent Trial and Appeal Board (PTAB) remains a hot topic in patent law. The Director first…
Read More →
The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters on July 16, 2024,…
Read More →
On July 17, 2024, the U.S. Patent Office issued additional guidance regarding patentability and inventorship concerns relating to Artificial Intelligence.…
Read More →
On July 17, 2024—but just recently posted to the Office of Prescription Drug Promotion (OPDP) of the U.S. Food and…
Read More →
In March 2022, the In re Zostavax MDL court entered a Lone Pine order requiring plaintiffs who claimed to have…
Read More →